Clinical Trial

Comparison of the Efficacy of Transcranial Direct Current Stimulation (tDCS) of the Primary Motor Cortex (M1) or the Prefrontal Cortex Combined With Aerobic Activity for Alleviation of Fibromyalgia Symptoms.

Unknown
View on ClinicalTrials.gov →
Record status
This record was last updated February 16, 2024 (before its estimated March 2026 completion). Its status may not reflect the trial's current state.
Summary
The goal of this study is to demonstrate the effectiveness of treating fibromyalgia using combination of electrical stimulation with aerobic activity. Participants will be randomly assigned to stimulation in a ratio of 1:1:1. 120 participants (40 in each group). The therapeutic course will include moderate aerobic physical activity (at 60% of the target heart rate adjusted for age) 3 times a week for 4 weeks (a week of adjustment, and 3 weeks of treatment), along with low current electrical stimulation for 3 weeks.
Protocol Amendment History 1 change
critical Trial status changed: Not Yet Recruiting → Unknown 2026-08-09
Trial Details
NCT Number NCT06263972
Lead Sponsor HaEmek Medical Center, Israel
Collaborators: Technion, Israel Institute of Technology, Rambam Health Care Campus
Conditions Fibromyalgia, Electric Shock
Enrollment 120 participants
Start Date 2024-03
Primary Completion 2026-03 (estimated)
Study Completion 2026-07 (estimated)
Updated on ClinicalTrials.gov 2024-02-16